Ariad Pharmaceuticals, Inc. Stock
Equities
US04033A1007
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2017 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
2014 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Managers | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Teresa Bitetti
PSD | President | - | - |
Tetsu Inada
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- Stock